Quest Diagnostics

Yahoo Finance • 2 months ago

Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation

SECAUCUS, N.J. and TORONTO, Aug. 26, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its acquisition of LifeLabs from OMERS. The transaction, valu... Full story

Yahoo Finance • 3 months ago

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J., Aug. 14, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.75 per share, payable on October... Full story

Yahoo Finance • 3 months ago

Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday?

Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday? On Tuesday, Wall Street saw a mixed session, with small-cap stocks outperforming large caps as inve... Full story

Yahoo Finance • 3 months ago

Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024

Second quarter revenues of $2.40 billion, up 2.5% from 2023 Second quarter reported diluted earnings per share ("EPS") of $2.03, down 1.0% from 2023; and adjusted diluted EPS of $2.35, up 2.2% from 2023 Full year 2024 revenues now expected... Full story

Yahoo Finance • 8 months ago

Ten Years Running: FORTUNE Names Quest Diagnostics One of 2024 "World's Most Admired Companies"

SECAUCUS, NJ / ACCESSWIRE / February 27, 2024 / Quest Diagnostics (NYSE:DGX), the nation's leading provider of diagnostic information services, announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2024... Full story

Yahoo Finance • 9 months ago

Quest Diagnostics Inc (DGX) Reports Mixed 2023 Results and Sets Positive Outlook for 2024

Revenue: Full year revenues decreased by 6.4% to $9.25 billion in 2023. Net Income: Reported net income for 2023 was $854 million, a 9.7% decrease from 2022. Earnings Per Share (EPS): Adjusted diluted EPS for the full year was $8.71, down... Full story

Yahoo Finance • 10 months ago

Quest Diagnostics to Release Fourth Quarter and Full Year 2023 Financial Results on February 1, 2024

SECAUCUS, N.J., Jan. 17, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2023 financial results o... Full story

Yahoo Finance • 10 months ago

Fitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic Health

Study to evaluate how behavioral and sensor data from wearables and blood tests can be leveraged to help individuals better assess and manage their metabolic health SECAUCUS, N.J., Jan. 17, 2024 /PRNewswire/ -- Fitbit and Quest Diagnostic... Full story

Yahoo Finance • 10 months ago

Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing

Goal to combine Ultima’s highly sensitive, low-cost technology with Quest’s oncology expertise and national scale in order to improve patient access, affordability and outcomes FREMONT, Calif & SECAUCUS, N.J., January 09, 2024--(BUSINESS... Full story

Yahoo Finance • 10 months ago

No-Cost Testing Helps Bolster I-HEAL Community Wellness Day in Mississippi Delta Region

NORTHAMPTON, MA / ACCESSWIRE / January 4, 2024 / Quest Diagnostics recently provided no-cost Blueprint for Wellness® testing to more than 100 local community members who attended a wellness day in the Mississippi Delta region. The ninth an... Full story

Yahoo Finance • 10 months ago

Quest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer

Seasoned healthcare executive and oncologist joins Executive Leadership Team SECAUCUS, N.J., Dec. 20, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced th... Full story

Yahoo Finance • 11 months ago

Haystack Oncology and Rutgers Cancer Institute Collaborate to use Haystack MRD™ in Clinical Study of Early-Stage Triple-Negative Breast Cancer

BALTIMORE, Dec. 14, 2023 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, has entered into a collaboration with Rutgers Cancer Institute of New Jersey to use Haystack Oncology's industry-leading personalized MRD... Full story

Yahoo Finance • 11 months ago

Universal DX Announces Strategic Collaboration With Quest Diagnostics To Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States

UDX also announces the initial closing of its series B financing of approximately $70 million with investors, including Quest Diagnostics Financing to support UDX's pursuit of FDA premarket approval for its colorectal cancer screening blo... Full story

Yahoo Finance • 12 months ago

Quest Diagnostics Launches Mobile Phlebotomy Service, Enabling Convenient At-Home Specimen Collection in the United States

Quest Mobile™ has 5,000 trained mobile phlebotomists whose reach will extend to 44 states by the end of 2023 SECAUCUS, N.J., Nov. 9, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic informati... Full story

Yahoo Finance • last year

Quest Diagnostics Incorporated (NYSE:DGX) Q3 2023 Earnings Call Transcript

Quest Diagnostics Incorporated (NYSE:DGX) Q3 2023 Earnings Call Transcript October 24, 2023 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.22, expectations were $2.19. Operator: Welcome to the Quest Diagno... Full story

Yahoo Finance • last year

Analysis of Half a Billion Lipid Tests from Five Continents Reveals Wide Variation of Heart Disease Lipid Risk by Country and Sex

Toronto, Ontario, July 10, 2023 (GLOBE NEWSWIRE) -- A new analysis of more than 460 million lipid test results of patients living in 17 countries on five continents provides new evidence that where a person lives and their sex influence... Full story

Yahoo Finance • last year

Quest Diagnostics to Release Second Quarter 2023 Financial Results on July 26, 2023

SECAUCUS, N.J., June 21, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2023 financial results on Wednesday, Ju... Full story

Yahoo Finance • last year

New Tests Yield Actionable Insights

NORTHAMPTON, MA / ACCESSWIRE / June 19, 2023 / Quest Diagnostics "With the knowledge from pharmacogenomics, we were able to get my medication therapy to a very good point, without the negative side effects. It's made a big difference for... Full story

Yahoo Finance • last year

Environmental Sustainability Drives Operational Excellence

NORTHAMPTON, MA / ACCESSWIRE / June 13, 2023 / Quest Diagnostics The COVID-19 pandemic had a dramatic impact on our operations, including our testing mix, which affected our environmental metrics. As Quest transitions to the post-pandemic... Full story

Yahoo Finance • last year

Post-Accident Workforce Drug Positivity for Marijuana Reached 25-Year High in 2022, Quest Diagnostics Drug Testing Index Analysis Finds

Increase Seen in the General U.S. Workforce Started Same Year First States Legalized Recreational Marijuana Overall Workforce Drug Test Positivity Persisted at Two-Decade High Across All Workers Marijuana and Amphetamines Positivity Clim... Full story